Epstein-Barr virus and multiple sclerosis

Epidemiology

Volumn 11, Issue 2, 2000, Pages 220-224

  Ascherio, Alberto ^a   Munch, Mette ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Blood antibodies; Case control studies; Epstein Barr Virus; Meta analysis; Multiple sclerosis; Viral infections

Indexed keywords

AUTOIMMUNITY; EPSTEIN BARR VIRUS; IMMUNE RESPONSE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; MULTIPLE SCLEROSIS; PREVALENCE;

EID: 0034001316     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-200003000-00023     Document Type: Review

References (55)

1. Martyn CN. 1. The epidemiology of multiple sclerosis. In: Matthews WB, Compston A, Allen IV, Martyn CN, eds. McAlpine's Multiple Sclerosis. 2nd ed. New York: Churchill Livingstone, 1991.
2. Wucherpfennig KW, Weiner HL, Hafler DA. T-cell recognition of myelin basic protein. Immunol Today 1991;12:277-282.
3. Kurtzke JF. MS epidemiology world wide. One view of current status. Acta Neurol Scand 1995;161(suppl):23-33.
4. Granieri E, Casetta I. Part III. Selected reviews. Common childhood and adolescent infections and multiple sclerosis. Neurology 1997;49(suppl):S42-S54.
5. Detels R, Brody JA, Edgar AH. Multiple sclerosis among American, Japanese and Chinese immigrants to California and Washington. J Chronic Dis 1972;25:3-10.
6. Alvord EC, Jr., Jahnke U, Fischer EH, Kies MW, Driscoll BF, Compston AS. The multiple causes of multiple sclerosis: the importance of age of infections in childhood. J Child Neurol 1987;2:313-321.
7. Riise T, Gronning M, Klauber MR, Barrett-Connor E, Nyland H, Albrektsen G. Clustering of residence of multiple sclerosis patients at age 13 to 20 years in Hordaland, Norway. Am J Epidemiol 1991;133:932-939.
8. Warner HB, Carp RI. Multiple sclerosis and Epstein-Barr virus (Letter). Lancet 1981:1290.
9. Munch M, Riisom K, Christensen T, Moeller-Larsen A, Haahr S. The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients? Acta Neurol Scand 1998;97:171-174.
10. Munch M, Hvas J, Christensen T, Moeller-Larsen A, Haahr S. The implications of Epstein-Barr virus in multiple sclerosis - a review. Acta Neurol Scand 1997;169(suppl):59-64.
11. Shirodaria PV, Haire M, Fleming E, Merrett JD, Hawkins SA, Roberts SD. Viral antibody titers: comparison in patients with multiple sclerosis and rheumatoid arthritis. Arch Neurol 1987;44:1237-1241.
12. Larsen PD, Bloomer LC, Bray PF. Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis. Neurology 1985;35:435-438.
13. Operskalski EA, Visscher BR, Malmgren RM, Detels R. A case-control study of multiple sclerosis. Neurology 1989;39:825-829.
14. Lindberg C, Andersen O, Vahlne A, Dalton M, Runmarker B. Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis. Neuroepidemiology 1991;10:62-65.
15. Martyn CN, Cruddas M, Compston DAS. Symptomatic Epstein-Barr virus infection and multiple sclerosis. J Neurol Neurosurg Psychol 1993;56:167-168.
16. Haahr S, Koch-Henriksen N, Moeller-Larsen A, Eriksen LS, Andersen HMK. Increased risk of multiple sclerosis after late Epstein-Barr virus infection. Acta Neurol Scand 1997;169(suppl):70-75.
17. Rickinson AB, Kieff E. Epstein-Barr Virus. In: Fields BN, Knipe DM, Howley PM, et al, eds. Fields Virology. Philadelphia: Lippincott-Raven, 1996;2397-2446.
18. Paterson RL, Kelleher C, Amankonah TD, Streib JE, Wu Xu J, Jones JF, Gelfand EW. Model of Epstein-Barr virus infection of human thymocytes: expression of viral genome and impact on cellular receptor expression in the T-lymphoblastic cell line, HPB-ALL. Blood 1995;85:456-464.
19. Dreyfus DH, Kelleher CA, Jones JF, Gelfand EW. Epstein-Barr virus infection of T cells: implications of altered T-lymphocyte activation, repertoire development and autoimmunity. Immunol Rev 1996;152:89-110.
20. Vaughan JH. The Epstein-Barr virus in autoimmunity. Springer Semin Immunopathol 1995;17:203-230.
21. Vaughan JH, Ruse T, Rhodes GH, Nguyen MD, Barrett-Connor E, Nyland H. An Epstein-Barr virus-related cross reactive autoimmune response in multiple sclerosis in Norway. J Neuroimmunol 1996;69:95-102.
22. James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJA, Harley JB. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997;100:3019-3026.
23. Vaughan JH, the Epstein-Barr virus and systemic lupus erythematosus. J Clin Invest 1997;100:2939-2940.
24. Scotet E, David-Ameline J, Peyrat M-A, Aubry-Moreau A, Pinczon D, Lim A, Even J, Semana G, Berthelot J-M, Breathnach R, Bonneville M, Houssaint E. T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J Exp Med 1996;184:1791-1800.
25. Koide J, Takada K, Sugiura M, Sekine H, Ito T, Saito K, Mori S, Takeuchi T, Uchida S, Abe T. Spontaneous establishment of an Epstein-Barr virus-infected fibroblast line from the synovial tissue of a rheumatoid arthritis patient. J Virol 1997;71:2478-2481.
26. Takei M, Mitamura K, Fujiwara S, Horie T, Ryu J, Osaka S, Yoshino S, Sawada S. Detection of Epstein-Barr virus-encoded small RNA 1 and latent membrane protein 1 in synovial lining cells from rheumatoid arthritis patients. Int Immunol 1997;9:739-743.
27. Wen S, Shimizu N, Yoshiyama H, Mizugaki Y, Shinozaki F, Takada K. Association of Epstein-Barr virus (EBV) with Sjogren's syndrome: differential EBV expression between epithelial cells and lymphocytes in salivary glands. Am J Pathol 1996;149:1511-1517.
28. Vento S, Guella L, Mirandola F, Cainelli F, Di Perri G, Solbiati M, Ferraro T, Concia E. Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals. Lancet 1995;346:608-609.
29. Bray PF, Bloomer LC, Salmon VC, Bagley MH, Larsen PD. Epstein-Barr Virus infection and antibody synthesis in patients with multiple sclerosis. Arch Neurol 1983;40:406-408.
30. Chalmers I, Altman DG, eds. Systematic Reviews. London: BMJ Publishing Group, 1995.
31. Kinnunen E, Valle M, Piirainen L, Kleemola M, Kantanen M-L, Juntunen J, Klockars M, Koskenvuo M. Viral antibodies in multiple sclerosis: A nationwide co-twin study. Arch Neurol 1990;47:743-746.
32. Woyciechowska JL, Dambrozia J, Leinikki P, Shekarchi C, Wallen W, Sever J, McFarland H, McFarlin D. Viral antibodies in twins with multiple sclerosis. Neurology 1985;35:1176-1180.
33. Poskanzer DC, Sever JL, Sheridan JL, Prenney LB. Multiple sclerosis in the Orkney and Shetland Islands: IV: Viral antibody titres and viral infections. J Epidemiol Community Health 1980;34:258-264.
34. Compston DA, Vakarelis BN, Paul E, McDonald WI, Batchelor JR, Mims CA. Viral infection in patients with multiple sclerosis and HLA-DR matched controls. Brain 1986;109:325-344.
35. Sumaya CV, Myers LW, Ellison GW. Epstein-Barr virus antibodies in multiple sclerosis. Arch Neurol 1980;37:94-96.
36. Sumaya CV, Myers LW, Ellison GW, Ench Y. Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. Ann Neurol 1985;17:371-377.
37. Myhr K-M, Riise T, Barrett-Connor E, Myrmel H, Vedeler C, Gronning M, Kalvenes MB, Nyland H. Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway. J Neurol Neurosurg Psychiatry 1998; 64:539-542.
38. Ferrante P, Castellani P, Barbi M, Bergamini F. The Italian Cooperative Multiple Sclerosis case-control study: preliminary results on viral antibodies. Ital J Neurol Sci 1987;6(suppl):45-50.
39. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia: Lippincott-Raven Publishers, 1998.
40. Mehta CR, Patel NR, Gray R. Computing an exact confidence interval for the common odds ratio in several 2 × 2 contingency tables. J Am Stat Assoc 1985;80:969-973.
41. Centers for Disease Control and Prevention. CDC - Epiinfo 6: a word processing, database and statistics program for public health. Version 6.02. Atlanta: Centers for Disease Control and Prevention, 1994.
42. Niederman JC, Evans AS. Epstein-Barr virus. In: Evans AS, Kaslow RA, eds. Viral Infections of Humans: Epidemiology and Control. 4th ed. New York: Plenum Medical Book Co., 1997.
43. Kurtzke JF, Page WF. Epidemiology of multiple sclerosis in US veterans: VII. Risk factors for MS. Neurology 1997;48:204-213.
44. Lio D, Caccamo N, D'Anna C, Cigna D, Candore G, Caruso C. Viral antibody titers are influenced by HLA-DR2 phenotype. Exp Clin Immunogenet 1994;11:182-186.
45. Cremer NE, Johnson KP, Fein G, Likosky WH. Comprehensive viral immunology of multiple sclerosis. II. Analysis of serum and CSF antibodies by standard serologic methods. Arch Neurol 1980;37:610-615.
46. Lycke J, Svennerholm B, Hjelmquist E, Friesén L, Badr G, Andersson M, Vahlne A, Andersen O. Acyclovir treatment of relapsing-remitting multiple sclerosis: A randomized, placebo-controlled, double-blind study. J Neurol 1996;243:214-224.
47. Soldan SS, Berti R, Salem N, Secchiero P, Flamand L, Calabresi PA, Brennan MB, Maloni HW, McFarland HF, Lin H-C, Patnaik M, Jacobson S. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nature Med 1997;3:1394-1397.
48. Fillet A-M, Lozeron P, Agut H, Lyon-Caen O, Liblau R. HHV-6 and multiple sclerosis (Letter). Nature Med 1998;4:537.
49. Coates ARM, Bell J. HHV-6 and multiple sclerosis. Nature Med 1998;4: 537-538.
50. Martin C, Enbom M, Söderström M, Fredrikson S, Dahl H, Lycke J, Bergström T, Linde A. Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol Scand 1997;95:280-283.
51. Bansil S, Troiano R, Dowling PC, Cook SD. Measles vaccination does not prevent multiple sclerosis. Neuroepidemiology 1990;9:248-254.
52. Gale CR, Martyn CN. Migrant studies in multiple sclerosis. Prog Neurobiol 1995;47:425-448.
53. Beebe G, Kurtzke JF, Kurland LT, Auth TL, Nagler B. Studies on the natural history of multiple sclerosis. 3. Epidemiologic analysis of the Army experience in World War II. Neurol 1967;17:1-17.
54. Russell WR. Multiple sclerosis: occupation and social group at onset. Lancet 1971;832-834.
55. Munch M, Hvas J, Christensen T, Møller-Larsen A, Haahr S. A single subtype of Epstein-Barr virus in members of multiple sclerosis clusters. Acta Neurol Scand 1998;98:395-399.